Archive

Artificial intelligence helps predict whether antidepressants will work in patients

Written by | 8 Feb 2024

In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the […]

2 common types of antidepressants were safe for most stroke survivors

Written by | 1 Feb 2024

Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference […]

Coming off antidepressants can trigger emotional and social difficulties alongside physical withdrawal symptoms

Written by | 19 Jan 2024

Coming off antidepressants is known to trigger physical symptoms, such as restlessness, fatigue and excessive sweating, but new research suggests people can also experience emotional and social difficulties, […]

Esketamine shows higher efficacy than quetiapine in treatment-resistant depression

Written by | 19 Oct 2023

Researchers report that patients treated for treatment-resistant depression with esketamine NS (nasal spray), a form of ketamine, achieve better and more durable outcomes than similar patients treated with […]

People living with HIV at substantially higher risk of depression and suicide, especially in first 2 years after diagnosis

Written by | 9 Apr 2023

People living with HIV (PLWH) are far more likely to be diagnosed with depression, take antidepressants, be treated with electroconvulsive therapy, and commit suicide than population controls, especially […]

Scientists explain emotional ‘blunting’ caused by common antidepressants

Written by | 24 Jan 2023

Scientists have worked out why common anti-depressants cause around a half of users to feel emotionally ‘blunted’. In a study published today, they show that the drugs affect […]

Vitamin D supplementation seems to alleviate depressive symptoms in adults

Written by | 15 Aug 2022

An extensive meta-analysis suggests that vitamin D supplementation may alleviate depressive symptoms in adults with depression. Conducted by an international team of researchers, the meta-analysis includes dozens of […]

Low addiction risk with medical use of ketamine

Written by | 6 Aug 2022

Commonly used in medicine as an anaesthetic, ketamine is also increasingly prescribed to relieve depressive symptoms. This very fast-acting psychotropic drug is particularly indicated for the treatment of […]

Psychotherapy found to be ineffective or unavailable for medicated patients with severe depression

Written by | 8 Jun 2022

Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy. Now a major ongoing international study has shown that adding psychotherapy treatment to […]

Antidepressants may improve outcomes in persons with diabetes and depression

Written by | 31 Jul 2021

Researchers report that patients diagnosed with both diabetes and depression who are treated with antidepressants appear to achieve a lower risk of death and of serious diabetes complications. […]

How do antidepressants trigger fear and anxiety?

Written by | 9 May 2021

More than 100 million people worldwide take selective serotonin reuptake inhibitors (SSRIs), such as Prozac and Zoloft, to treat depression, anxiety and related conditions, but these drugs have […]

Urgent shortage of evidence for safe withdrawal from antidepressants

Written by | 27 Apr 2021

A new study has highlighted that while much is known about the ever increasing uptake of antidepressant medications around the world, there is very little evidence on safe […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.